IU Health People Mover train to shut down indefinitely
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
Health Care
Articles
Report: U.S. health spending hits $3.5T, but growth slows
The rate of growth slowed for the second year in a row, according to economic experts at the federal Health and Human Services department.
Entrepreneur finds financial success with deep-tissue therapy
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
Carmel spine surgeon wins $112M verdict in royalty battle with Medtronic
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
Riley Children’s Foundation announces $175 million campaign
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
Riverview Health chooses north Carmel site for new facility
Riverview Health plans to build one of its new freestanding combined ER/urgent care facilities on Hazel Dell Road, south of 146th Street.
Developer spending $15M to build senior villas on 86th Street
A senior housing community east of the St. Vincent Hospital campus is expected to undergo a major expansion over the next year that will add several dozen independent-living residences.
Rising fear among Asians leads Eli Lilly to rethink employee groups
New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.
State police collect unused medicines
Indiana State Police collected more than a ton of expired and unwanted prescription medications Oct. 27 as part of the national “Prescription Drug Take Back” initiative sponsored by the U.S. Drug Enforcement Administration.
Opioid war rages on, but those on the front lines see progress
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
Americans, Canadians warned not to eat romaine lettuce
FDA Commissioner Scott Gottlieb said the FDA wanted to issue a warning about a new E. coli outbreak before people gathered for Thanksgiving meals, where the potential for exposure could increase.
Former Marsh store in Castleton area lands new tenant
Jane Pauley Community Health Center plans to fill about a third of the space, which was vacated by defunct grocery chain Marsh Supermarkets in May 2017.
Jennie-O recalling ground turkey in salmonella outbreak
Regulators say additional products from other companies could be named as their investigation continues.
Eli Lilly considering sale of China assets to raise cash
Indianapolis-based Lilly is working with advisers to gauge interest in selling off a selection of older drugs for antibiotics and central nervous system diseases in China.
Two IU researchers win $2.3M grant to study neuropathy in cancer patients
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
E-cigarettes facing new sales restrictions from FDA
New limitations will be placed on e-cigarettes, according to a senior FDA official, restricting sales of many popular fruit flavors amid what the health agency has called an epidemic of youth use.
Lilly raises guidance after topping profit, revenue expectations
Lilly’s revenue in the United States rose 11 percent year-over-year, to $3.4 billion, thanks largely to rising sales of diabetes drugs Trulicity and Basgalar, cancer treatment Verzenio and psoriasis medication Taltz.
Endocyte insiders to reap millions from Novartis deal
Executives and directors of the West Lafayette-based biotech hold nearly 9 percent of Endocyte stock, worth about $177 million, based on the deal price of $24 a share.
Hamilton County officials debate 10 percent income tax hike for 911
For at least a year, county officials have debated how best to pay for the county’s 911 communications operation going forward.
Eli Lilly partner urges investors to look beyond biotech turmoil
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.